Introduction
============

Despite being discovered about 70 years ago, ZIKV had not gained much public health attention until its massive outbreak in Brazil in 2015, whereby it has been suggested as a causative agent of microcephaly and other congenital birth defects in human newborns whose mothers were exposed to ZIKV during their first trimester of pregnancy ([@B7]). In addition, ZIKV infection can cause *Guillain*-*Barré* syndrome and meningoencephalitis in adults ([@B39]; [@B8]). ZIKV is primarily transmitted to humans by the *Aedes* species of mosquitos ([@B25]), but can also be acquired through other routes, such as sexual intercourse ([@B16]; [@B48]). Currently, ZIKV infection is causing significant public health concerns, however, its pathogenesis is incompletely understood, and there is no approved therapeutic or vaccine available.

Studies have documented that ZIKV primarily targets both human and mouse neural progenitor cells, resulting in cell death and disruption of neurogenesis, including neuronal proliferation, differentiation, and migration ([@B14]; [@B22]; [@B30]; [@B38]; [@B49]). For instance, direct inoculation of ZIKV into the lateral ventricle of mouse fetuses (C57 or ICR strain), or into the amniotic fluid of the uterus (C57BL/6) ([@B13]), or intraperitoneal (i.p.) inoculation of pregnant mice (C57 or C57BL/6) at embryonic days 13.5--15.5 can result in disruption of fetal neural progenitor cells and cortical development ([@B30]; [@B46]; [@B56]). Immunocompetent mice are less susceptible to ZIKV-mediated complications because ZIKV does not antagonize the mouse type I interferon response like it does in humans ([@B23]; [@B29]; [@B36]; [@B43]). It has been shown, the non-structural protein NS5 of ZIKV selectively degrades the IFN-regulated transcriptional activator STAT2 in humans, but not in mice ([@B23]). Therefore, recent studies used various immunodeficient or immune-manipulated mouse strains to study the impact of congenital ZIKV infection on fetal development. For instance, ZIKV infection in pregnant SJL mice (T and B cell dysfunction) or mice with partial interferon function deficiency, resulted in fetal demise, intrauterine growth restriction, and signs of microcephaly in newborns, while no apparent anomalies were observed in pups from ZIKV-infected (i.p., intravenously, or subcutaneously) immunocompetent (C57BL/6) dams at birth ([@B12]; [@B34]). Yet, data from these studies may not recapitulate most human infections due to the immune compromised state of the mice. Recently, post-natal behavioral abnormalities were observed in (C57BL/6) mice that were inoculated directly within the amniotic fluid of the uterus, resulting in ocular deficits that contributed to behavioral deficits, however viral RNA was detected in fetal brains at birth and at day 8 post-birth ([@B13]), indicating viral infection lasted into postnatal development in this model. In contrast, the majority of human infants born to mothers who were exposed to ZIKV during their first trimester of pregnancy were free of viral RNA and appeared healthy at birth, as the chance of developing congenital microcephaly, is between 13--15 percent ([@B9]; [@B28]; [@B42]). Considering the severe effects of ZIKV infection on neural progenitor cells, it is possible that even a transient congenital ZIKV infection during embryonic development could result in long-term defects during postnatal developmental, even if no prominent symptoms are observed at birth. This also holds true for other congenital viral infections, such as cytomegalovirus (CMV) and rubella, which can both cause postnatal manifestations in infants, such as seizures, hearing loss and neurodevelopmental delays, with no obvious abnormalities noticed at birth ([@B45]; [@B21]). Furthermore, the contribution and/or degree of maternal and fetal inflammation triggering neurodegeneration *in utero* must also be considered in order to better understand the mechanisms involved neuropathological progression post birth ([@B6]; [@B19]; [@B53]; [@B26]). Most importantly, recent evidence has surfaced that some normal appearing neonates born to ZIKV-infected pregnant women have developed postnatal microcephaly symptoms including brain neuroimaging abnormalities, head growth restrictions, and behavioral deficits months after birth ([@B32]; [@B51]). In addition, the complex involvement of co-morbid neurodevelopmental sequelae of infants that were exposed to ZIKV *in utero* has also been described in infants months to years after birth; for example, motor abnormalities, such as dyskinesia, hypertonia, and spasticity, have been observed together with seizures ([@B41]). In line with this, intra-amniotic infection of immunocompetent murine dams identified co-morbid motor deficits, such as rota-rod latency and gait/stride disturbances in pups, which may have been attributed to vision disparities ([@B13]). Therefore, there is an urgent need to develop an animal model that mimics human infection, to study the long-term developmental consequences of congenital ZIKV infection. Considering that ZIKV infection in immunocompetent mice is transient and self-limiting, we used this mouse model to assess potential ZIKV-associated postnatal developmental sequelae. Our results showed that newborn pups from ZIKV infected immunocompetent dams were free of ZIKV RNA and had similar head size and body weight with mock-infected control pups, yet manifested postnatal growth impediments and neurobehavioral deficits that persisted into adulthood. Thus, our mouse model can be used to mimic and evaluate the potential outcomes of a mild, transient prenatal ZIKV infection in human babies.

Results and Discussion
======================

To study the postnatal developmental impacts of congenital ZIKV infection in mouse pups (denoted ZIKV-pups), we inoculated pregnant immunocompetent C57BL/6J mice intraperitoneally (i.p.) at embryonic day (E) 8.5 with PBS (mock) or 10^4^ PFU of ZIKV strain PRVABC59, which is closely related to the epidemic strains that have been linked to human microcephaly in the Americas ([@B18]). Although at low levels, dams exposed to ZIKV developed viremia (**Supplementary Figure [S1A](#SM1){ref-type="supplementary-material"}**), confirming that both ZIKV can infect immunocompetent dams. Importantly, ZIKV RNA and infectious viral particles were detected in majority of the uteruses, placentas, and in fetal head and body tissues on day 2 post-infection (p.i.), indicating that ZIKV can infect the developing fetuses via the i.p. inoculation route (**Figures [1A,B](#F1){ref-type="fig"}**). In addition, maternal antibody- and type I interferon-mediated immunity ([@B34]; [@B57]) (**Supplementary Figures [S1B,C](#SM1){ref-type="supplementary-material"}**) may have assisted in clearance of the virus, as ZIKV RNA was not detected in newborn ZIKV-pups brain tissue at birth (data not shown). Consistent with previous reports ([@B12]; [@B34]), ZIKV- and mock-pups have comparable body weights at birth (**Figure [1C](#F1){ref-type="fig"}**), indicating that a mild congenital ZIKV infection in immunocompetent mice does not cause gross abnormalities at birth, in contrast to severe developmental and birth defects that were reported in pups born to ZIKV infected immunodeficient mice ([@B12]; [@B34]). After birth, pups were monitored up to 17 weeks (120 days) to assess their growth, and any postnatal developmental and behavioral abnormalities. Interestingly, we found that ZIKV-pups gained less body weight than mock-pups approximately from D19 post-birth (p.b.) to the end of our experiments on D120 p.b. (**Figure [1C](#F1){ref-type="fig"}**), though ZIKV- and mock-infected dams have comparable body weights during both pregnancy and nursing periods (**Supplementary Figure [S1D](#SM1){ref-type="supplementary-material"}**) and gave birth to similar litters in terms of numbers and sex (data not shown). Furthermore, ZIKV-pups had statistically smaller head circumferences (**Figure [1D](#F1){ref-type="fig"}**) and smaller head and ear sizes (**Figure [1E](#F1){ref-type="fig"}**), than mock-pups. Collectively, these results suggested that a transient and mild congenital i.p. ZIKV infection could result in postnatal growth and developmental deficits in mouse pups, although no abnormalities were observed at birth.

![ZIKV-pups exhibit postnatal growth impediment. Dams were infected with ZIKV (10^4^ PFU, i.p.) or mock infected on E8.5. On D2 p.i. (E10.5), ZIKV-*E* RNA **(A)** or infectious virions **(B)** in maternal uterus, placenta, fetal head and fetal body (*n* = 4--6 dams) were measured by qPCR or plaque assay (horizontal dash lines denote detection limit). **(C)** Pup body weight in grams (g) (*n* = 11--65). **(D)** Head circumference of pups (*n* = 11--58). **(E)** Pup head and ear size measurements: "1", length between outer corner of eye to base of ear; "2", length from base of chin to top of head; "3", length of ear from base to top (midline); and "4", width of ear, *n* = 20--59 at D12, D19, and D40 p.b. All head and body measurements were blinded from the investigator handling the mice. The results were analyzed using a two-tailed Student's *t*-test (^∗^denotes *p* \< 0.05, when compared to mock; center values are means and error bars represent s.e.m.).](fmicb-09-02028-g001){#F1}

To determine if these postnatal deficits were associated with neuron function, we assessed various neurodevelopmental behaviors in ZIKV- and mock-pups. These assessments included balance, motor coordination, forelimb strength, and cognitive development. The results showed that compared to mock-pups at selected time points p.b., ZIKV-pups had trends in poor balance (**Figure [2A](#F2){ref-type="fig"}**) and weak fore-limb strength (**Figure [2B](#F2){ref-type="fig"}**), suggesting motor coordination disparities. Along with a significant increase in passivity and decrease in locomotion, indicating a deficit in motor or motivational behavior (**Figures [2C,D](#F2){ref-type="fig"}**). While, the cognitive memory T-maze test indicated a significant increase in the time it took to enter a reward-containing arm, with a trend in increased errors made to enter the same arm (**Figures [2E,F](#F2){ref-type="fig"}**). These behavior results indicated that even a mild congenital ZIKV infection could cause postnatal neurobehavioral defects, especially related to cognitive function. In support of these tests, a visual cliff recognition test indicated that ZIKV-pups were inclined to make poor decisions compared to mock-pups particularly in adulthood (**Supplementary Figure [S2A](#SM1){ref-type="supplementary-material"}**). In addition, ocular analyses displayed normal histology of the cornea, lens, angle, ciliary body and retina, indicating that the neurobehavioral deficits in ZIKV-pups might not be due to ocular defects in our model (**Supplementary Figure [S2B](#SM1){ref-type="supplementary-material"}**). Since in this model we intended to mimic a mild ZIKV infection in the majority of human infection cases by inoculating a low dose of ZIKV via i.p. in immunocompetent mice, it is possible that the viral infection levels in the fetuses varies (**Figures [1A,B](#F1){ref-type="fig"}**), which may explain why some ZIKV-pups manifested only mild neurobehavioral deficits, or even similar behaviors compared to mock-pups. We speculated that adjustment of the viral infection doses along with inoculation timing during embryonic development might affect the degree of postnatal neurobehavioral deficits. Nevertheless, our results indicated that a mild ZIKV infection *in utero* could cause both postnatal motor and memory impairments that persisted into adulthood.

![ZIKV-pups exhibit postnatal behavioral deficits. Pups born to dams infected with ZIKV (10^4^ PFU, i.p.) or mock infected on E8.5 were subjected to multiple behavioral tests. **(A)** Dowel test (s), *n* = 11--40; **(B)** Wire test (s), *n* = 11--40; **(C)** Bar cross test measurements of Passivity (s), *n* = 11--40; and **(D)** Locomotion (s), *n* = 11--40 and a T-Maze test of time to reward (s) and number of arm-entering errors (\#) at D60 p.b. *n* = 11--19 **(E)**, and D120 p.b. *n* = 11--19 **(F)**. All behavioral measurements were blinded from the investigator handling the mice or the investigator performing the analysis. The results were compared using a two-tailed Student's *t*-test (^∗^denotes *p* \< 0.05, when compared to mock; center values are means).](fmicb-09-02028-g002){#F2}

To further characterize the effect of congenital ZIKV infection on postnatal brain development, we compared brain weights and sizes of ZIKV- and mock-pups on D0, D12 and D19 p.b. Although ZIKV-pups had comparable brain weights with mock-pups on D0, their brain weights and sizes were smaller than mock-pups on D12 and D19 p.b. (**Figures [3A](#F3){ref-type="fig"}--[C](#F3){ref-type="fig"}**). Furthermore, three-dimensional (3D) magnetic resonance imaging (MRI) of whole brains on D19 p.b. revealed that ZIKV-pups had smaller brain volumes compared to mock-pups (**Figure [3D](#F3){ref-type="fig"}**). In addition, immunostaining of midsagittal brain sections showed cellular disarrangement and a thinner cortical layer 1 in the brains of ZIKV-pups at D19 p.b. (**Figures [4A,B](#F4){ref-type="fig"}**), a feature associated with microcephaly in human babies ([@B30]). In line with this, calcium-binding protein Calbindin-D28k positive neurons migrated into the layer 1 in the brains of ZIKV-pups (**Supplementary Figure [S3C](#SM1){ref-type="supplementary-material"}**), which are usually seen in layers four to six (L4-6) ([@B11]). It is important to note that cortical layer 1 formation in mouse fetal brain occurs between E8-10 of gestation ([@B11]), a time window that is similar to the first trimester of human pregnancy, whereby the developing fetus is most susceptible to develop ZIKV-mediated neurological deficits ([@B28]). Apart from cortical layer 1 thinness in ZIKV-pups at D40 p.b., the density of neurons within L1-6 of the cortex were also reduced (**Figures [4C,D](#F4){ref-type="fig"}**). Since memory deficits were observed in adult ZIKV-pups, but not in mock-pups, we next analyzed whole brain pathology of ZIKV-pups, which indicated differential cellular architecture, particularly within the CA1 and dentate gyrus regions of the hippocampus (**Figures [4Ei](#F4){ref-type="fig"}--[iii](#F4){ref-type="fig"}**). Interestingly, the subgranular zone of the dentate gyrus is the site for neurogenesis ([@B17]), and neural progenitor cells within this region are highly susceptible to ZIKV infection, resulting in cellular apoptosis ([@B31]; [@B56]). In comparison, both reduced neurons and marginal apoptosis were observed in the dentate gyrus region of the hippocampus in ZIKV-pups up to adulthood (**Figures [4Eiii,iv](#F4){ref-type="fig"}**), along with the neocortex (**Supplementary Figures [S3A,B](#SM1){ref-type="supplementary-material"}**) and the cerebellum (data not shown), suggesting that developmental memory deficits may be a result of disrupted postnatal neurogenesis and neural function. Furthermore, midsagittal brain sections were immunostained with GFAP to identify astrogliosis, a hallmark feature of human and mouse newborns with microcephaly ([@B35]; [@B46]). The GFAP immunostaining exhibited progressive astrogliosis near CA1 neurons of the hippocampus and within the white matter of the cerebellum of ZIKV-pups at D12, D19 and D60 p.b. (**Figure [4F](#F4){ref-type="fig"}**), along with enlarged astrocytes surrounding motor neurons within cervical spinal cords (**Supplementary Figure [S3D](#SM1){ref-type="supplementary-material"}**), while only minimal reactivity to GFAP was detected in these regions in mock-pups (**Figure [4F](#F4){ref-type="fig"}** and **Supplementary Figure [S3D](#SM1){ref-type="supplementary-material"}**). Reactive astrogliosis in the hippocampus and cerebellum has been linked to defective memory ([@B47]) and motor coordination ([@B10]) in mice, which were observed in our behavioral studies of ZIKV-pups (**Figures [2A](#F2){ref-type="fig"}--[F](#F2){ref-type="fig"}** and **Supplementary Figure [S2A](#SM1){ref-type="supplementary-material"}**). Consistent with our report, chronic astrogliosis, neurodegeneration and reduced cognitive neurobehavioral performances have also been observed following murine cytomegalovirus infection, even after the virus was cleared ([@B37]; [@B33]). Collectively, these observations suggested that a transient and mild ZIKV infection in immunocompetent mice during pregnancy could cause postnatal brain developmental deficits in pups.

![ZIKV-pups have smaller brains. Brains from pups born to dams infected with ZIKV (10^4^ PFU, i.p.) or mock infected on E8.5 were analyzed. **(A)** Representative brain images at D12 and D19 p.b. **(B)** Metric measurement of scaled-up images for resolution (a.u. denotes arbitrary units) of brain sections: "1," length of brain (midline) from top of olfactory bulb to bottom of cerebellum; "2," length of olfactory bulb; "3," width of cerebrum; "4," width of bottom of cerebrum; "5," length from midline of olfactory bulb (bottom) to side of cerebrum, at D12 p.b., *n* = 8 and D19 p.b., *n* = 13--16. **(C)** Weight (mg) of brains (D0 p.b., *n* = 9--17; D12 p.b., *n* = 13--14; D19 p.b., *n* = 17--20). **(D)** 3D images and volume measurement (mm^3^) of brains from pups (*n* = 2) at D19 p.b. obtained by MRI. The brain measurements and weights were compared using a two-tailed Student's *t*-test and the MRI measurements were compared using a Mann--Whitney *U* test (^∗^denotes *p* \< 0.05; center values are means and error bars represent s.e.m).](fmicb-09-02028-g003){#F3}

![Congenital ZIKV infection causes a thinner cortical layer 1, dysregulated neuronal migration and astrogliosis. Brain sections of pups from ZIKV (10^4^ PFU, i.p.) or mock-infected dams on E8.5 were analyzed at various time points post-birth. **(A)** Representative images of cortical layers (L1-6) of D19 p.b. coronal brain sections stained with DAPI. **(B)** Layer 1 (L1) thickness measurements per 100× magnification field were quantified by using ImageJ software (*n* = 3). **(C)** Representative images of brains (D40 p.b.) stained with NeuN showing cortical layers 1--6 (L1-6, 400× magnification). **(D)** Quantification of NeuN^+^ cells in the coronal cortical sections per 400× magnification field at D40 p.b. (*n* = 3). **(E)** Anatomical images of **(i)** hippocampus at D19 p.b. (80× magnification); **(ii)** dentate gyrus at D40 p.b. (1000× magnification); **(iii)** NeuN^+^ dentate gyrus and hilar region of the hippocampus (400× magnification); and **(iv)** TUNEL labeled dentate gyrus and hilar region of the hippocampus (400× magnification, scale bar = 20 μm). **(F)** GFAP immunoreactivity (brown) and hematoxylin (purple) staining of midsagittal sections (D12, D19, and D60 p.b.) of the hippocampus CA1 labeled neurons (**i,** left panel); and the cerebellum (**ii,** right panel). DG, dentate gyrus; SGZ, subgranular zone; ML, molecular layer; PCL, Purkinje cell layer; GL, granule cell layer; WM, white matter. Images represent three biological samples from each group. The L1 thickness and the number of the NeuN^+^ cells were compared using a Mann--Whitney *U* test (^∗^denotes *p* \< 0.05; center values are means and error bars represent s.e.m.).](fmicb-09-02028-g004){#F4}

Zika virus, as a neurotropic virus, preferentially targets neural stem cells and immature neurons ([@B27]; [@B38]). Therefore, we also studied the impact of ZIKV infection on a global gene expression profile in murine neuroblasts (Neuro-2a) by mRNA sequencing (RNA-seq). Differential expression analysis revealed down-regulation of several neural development- and microcephaly- related genes including *Cenpf, Tbr2, Pax6, Dscaml1, Mmp15, Casc5, Rbbp8, Mcph1, Stil, and Wdr62* (**Figure [5A](#F5){ref-type="fig"}**). While similar neural developmental- and microcephaly- related genes were also measured in fetal head tissues and pups' brains by quantitative real-time PCR (qPCR). The results showed that the expression of *Cenpf* and the neurogenesis gene, *Sox1* ([@B52]), were reduced in the head tissue of ZIKV-infected fetuses on E10.5 (**Figure [5B](#F5){ref-type="fig"}**). Moreover, *Cenpf* (D0, 19, and 40 p.b.) and *Tbr2* (D0 and 40 p.b.) were significantly down-regulated in brains of ZIKV-pups compared to mock-pups, with no differences detected in *Mmp15* expression (**Figure [5B](#F5){ref-type="fig"}**). In humans, mutations in *Cenpf* are associated with congenital malformation syndromes and microcephaly ([@B55]; [@B20]). Similarly, silencing of transcription factor Eomes/Tbr2 during early fetal development could lead to disorders of neuronal migration, microcephaly ([@B5]; [@B4]), and behavioral deficits, including reduced hang wire strength of mouse pups ([@B4]), with this trend being observed in our ZIKV-pups (**Figure [2B](#F2){ref-type="fig"}**). Since the transcription of *Cenpf and Sox1* were reduced in the head tissue of ZIKV-infected fetuses on E10.5 (**Figure [5B](#F5){ref-type="fig"}**), we further confirmed down-regulation by qPCR analysis in Neuro-2a cells infected with ZIKV, while no difference was observed when cells were infected with another closely related flavivirus, West Nile virus (WNV, strain CT2741) (**Figure [5C](#F5){ref-type="fig"}**). Down-regulation of SOX1 and CENPF by ZIKV was further confirmed in ZIKV-infected Neuro-2a cells by flow cytometry (**Figure [5D](#F5){ref-type="fig"}**). Murine embryonic stem cells (ESCs) have the potential to differentiate into neuronal precursors, therefore, we sought to evaluate the effects of ZIKV infection on pre-neuronal development in our established *in vitro* ESC model ([@B24]). When ESCs are cultured in suspension, they grow into aggregates, forming embryoid bodies (EBs) and 3D structures that resemble an early embryo, whereby neurons and neuronal progenitors can be readily detected ([@B24]). In this model, we infected 5-day-old EBs with ZIKV to assess the expression of neurodevelopment- and microcephaly related genes, including *Sox1*, *β-tubulin III, Ng2*, *Nestin*, and *Cenpf* on days 6-8 (D6-8) by qPCR. The results also showed that ZIKV infection down-regulated the expression of multiple neuron-specific genes at a time frame that resembles early stages of embryogenesis (**Figure [5E](#F5){ref-type="fig"}**). Although more detailed research is warranted to define the roles of these genes in ZIKV infection, the altered expression of the microcephaly-related genes in the fetal brains may directly or indirectly result in the neuronal pathology, postnatal growth impediment, and neurobehavioral deficits in the ZIKV-pups.

![Zika virus down-regulates the expression of neural development- and microcephaly- related genes in Neuro-2a cells, ZIKV-pup brain tissue, and embryoid bodies. **(A)** Expression profile of neural development- and microcephaly- related genes in ZIKV-infected Neuro-2a cells by mRNA sequencing. **(B)** qPCR measurement of the expression of neuronal- and microcephaly-related genes in fetal brains on E10.5 (*n* = 12/group), and in pup brains on D0, D19, and D40 p.b. (*n* = 7--13/group). **(C)** qPCR analysis of the expression of *Sox1* and *Cenpf* in Neuro-2a cells infected with ZIKV and WNV, (MOI = 1) for 24 h. **(D)** Flow cytometric analysis of SOX1 and CENPF expression in Neuro-2a cells infected with ZIKV (MOI = 1) for 48 h. MFI, mean fluorescence intensity. **(E)** Expression of neural development- and microcephaly- related genes in embryoid bodies (EB) (6--8 days old) infected with ZIKV (10^4^ PFU). qPCR analyses are represented as relative fold change (RFC) and are normalized to cellular *β-actin*, with a definition of mock control as 1. Data were compared using a two-tailed, Student's *t*-test (^∗^denotes *p* \< 0.05; error bars represents s.e.m.). qPCR and flow cytometry experiments were repeated twice.](fmicb-09-02028-g005){#F5}

Congenital ZIKV infection in humans causes severe microcephaly at birth only in a small percent of babies ([@B9]; [@B28]; [@B42]), while some apparently healthy newborn babies can still develop postnatal congenital ZIKV syndromes including head growth restrictions and behavioral deficits, before 1 year of age ([@B6]; [@B19]). Consistent with our findings in mice, some human infants, without apparent microcephaly at birth, displayed postnatal syndromes of disproportionate head growth, while one baby developed difficulties moving its left hand months after birth. Not surprisingly, neuroimaging analyses suggested that babies who developed postnatal congenital ZIKV syndromes had a milder degree of brain damage compared to those with microcephaly at birth ([@B3]). Our ZIKV infection model in immunocompetent C57BL/6J mice causes brain widespread astrogliosis and mild neurobehavioral deficits in pups, which can partially mimic congenital ZIKV-causing postnatal developmental deficits in humans. In addition, ZIKV-pups developed cognitive deficits by measurement of the T-maze test that persisted into adulthood indicating even a mild congenital ZIKV infection could result in learning disabilities in humans.

While our current experimental design has some limitations, such as low viral RNA infection levels that were not detected in all fetal samples, our mouse model may mimic majority of human ZIKV infections. This mouse model can be further optimized by adjusting infection timing and increasing viral dose in that ZIKV-pups may display more robust neurobehavioral deficits, making this a valuable animal model to mimic human congenital ZIKV-caused postnatal developmental deficits. Although we cannot exclude the possibility that *in utero* inflammation may also contribute to the developmental deficits of ZIKV-pups, our results are consistent with other congenital viral infections, such as CMV and rubella, which can both cause postnatal manifestations in human infants ([@B45]; [@B21]), suggesting ZIKV infection during pregnancy could also lead to postnatal developmental deficits that may due to direct or indirect damages of ZIKV infection in neural progenitor cells.

In conclusion, our results showed that even a transient, mild congenital ZIKV infection in immunocompetent mice could lead to postnatal neurobehavioral deficits, suggesting it is necessary to closely monitor both physical and intellectual development in children whose mothers were exposed to ZIKV infection during pregnancy. In addition, our study also provides a valuable animal model to mimic human congenital ZIKV-infection caused postnatal developmental deficits.

Materials and Methods {#s1}
=====================

Ethics Statement and Biosafety
------------------------------

All animal care and experiments were conducted according to the Guide for the Care and Use of Laboratory Animals approved by The University of Southern Mississippi (USM) under the IACUC protocol \# 16031002. All *in vitro* experiments and animal studies involving live ZIKV and WNV were performed by certified personnel in biosafety level 2 and 3 laboratories following standard biosafety protocols approved by the USM Institutional Biosafety Committees.

Viruses, Animals, and Cells
---------------------------

Zika virus (strain PRVABC59) was obtained from B. Johnson (CDC Arbovirus Branch, Fort Collins, CO, United States) and WNV isolate (CT2741), kindly provided by John F. Anderson, were propagated in Vero cells (ATCC CCL-81). Viral stocks were titered in Vero cells by a plaque assay, as previously described ([@B40]). C57BL/6J mice were purchased from the Jackson Laboratory (Bar Harbor, ME, United States) and 9--10 week-old mice were paired for copulation. When vaginal plugs appeared (embryonic day, E0.5) pairs were separated. At E8.5, dams were inoculated i.p. with ZIKV (10^4^ PFU), or phosphate buffered saline (PBS) as mock control. Murine neuroblast cells (Neuro-2a, ATCC CCL-131) were cultured in DMEM supplemented with 10% FBS and 1% Pen/Strep at 37°C with 5% CO~2.~ Mouse ESCs (D3 cell line, ATCC) were maintained in mouse ESC medium. ESC differentiation through embryoid body (EB) formation was performed as previously described ([@B24]).

Quantitative PCR (qPCR) and Plaque-Forming Unit (PFU) Assay
-----------------------------------------------------------

Total RNA was extracted from tissues or cultured cells by using TRIreagent (Molecular Research Center, Inc.) and converted to cDNA using iSCRIPT cDNA synthesis kit (Bio-Rad). QPCR assays were performed using iTAQ polymerase supermix for probe-based assays (Bio-Rad) or iQ SYBR Green Supermix (Bio-Rad). Viral RNA of ZIKV *envelope (E)* ([@B1]) was measured by qPCR and infectious viruses were measured by plaque assay as we previously described ([@B2]). Threshold cycle values that were ≥39 cycles were excluded from the qPCR results, and 1 PFU per volume of sample was set as the limit of viral detection for the plaque assays. WNV-*envelope* (*E)* gene primers and probes sequences were adapted according to a previous publication ([@B50]). All additional gene primer sequences are described in **Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**.

Neurobehavioral Tests
---------------------

### Dowel Test

Balance and motor coordination was measured using a 24-inch long dowel (0.9 cm in diameter), attached to a bar cross apparatus and the time mice remained on the dowel was recorded for up to a maximum of 2 min, the longer time that mice remained on the dowel indicated balance/motor coordination disparity ([@B54]).

### Wire Suspension Test

As previously described ([@B44]), mice were hung onto a 3-mm wire with their forelimbs for 1 min and the time they took to fall (seconds) was recorded.

### Bar Cross Test

Mice were placed on one arm of a U-shaped bar cross apparatus (30 cm high and 18 mm wide) and allowed to move for 5 min. Locomotion time (duration of mobile activity) and passivity time (duration of total inactivity) was recorded ([@B54]).

### T-Maze Test

Mice were habituated (5 min/mouse) in a T-maze with dimensions previously described ([@B15]), for 5 days prior to testing. A side preference was noted during habituation days and on the test day; a mouse was placed in the starting arm, with the preferred arm closed and the other arm open (alternating arm test), with both arms containing a reward (Kellog's^®^ Fruitloops^®^). Once the mouse explored the maze by finding the reward and returning to the start arm, the closed arm was opened and the timer was started. The time it took (seconds) and the number or errors (entering incorrect arm) was recorded.

All the neurobehavioral tests were blinded to both the investigator performing the tests and another investigator collecting data.

Magnetic Resonance Imaging
--------------------------

Whole heads were collected on D19 p.b., fixed in 4% PFA for 96 h, and transferred to PBS until ready for MRI imaging. All MRI images were acquired with a GE Signa Excite HDx MR machine with a 3.0 T magnet. The skulls were individually placed into the Mayo Clinic BC-10 Wrist Coil (Part \#13G5614) and imaged using a Transverse T2 fast spin echo sequence. Sequence parameters included an 85 ms echo time (TE), 3350 ms repetition time (TR), 4 cm field of view, 12 echo train length (ETC), and 3 averages, with 1.0 mm slice thickness and 0.0 mm slice spacing. Image segmentation, 3D reconstruction, and dimensional quantifications were performed using Scan IP (Simpleware, United Kingdom).

Immunohistochemistry and Immunofluorescence
-------------------------------------------

Midsagittal and coronal brain sections (6 μm) at D12, D19, D40, and D60 p.b were probed with NeuN and GFAP specific antibodies, followed by labeling with Alexa 488 secondary antibody (Invitrogen) and DAPI and TUNEL for immunofluorescence, or biotinylated secondary antibody, developed with ExtrAvidin peroxidase immunostaining kit (Sigma), for immunohistochemistry. Non-specific Toluidine blue and hematoxylin staining was also performed. The slides were mounted with Aqua-mount (Fisher Scientific) and observed using an Epi-fluorescence (Olympus BX60) or bright-field microscope, and images were captured using a digital camera (DP70).

Flow Cytometry
--------------

Neuro-2a cells infected with ZIKV (MOI = 1) for 48 h were fixed in 4% PFA, probed with rabbit anti-CENPF or anti-SOX-1 antibodies (Abcam), followed by FITC-conjugated goat-anti-rabbit-IgG antibody (Santa Cruz). Cells were then washed twice and analyzed with a BD LSRFortessa flow cytometer (BD Biosciences) and data were acquired using the BD FACSDIVA^TM^ version 7.0 (BD Biosciences). Cells probed with secondary IgG antibodies were used as fluorescence gating controls.

RNA-Sequencing (RNA-seq)
------------------------

Neuro-2a cells were infected with ZIKV (MOI = 0.5) for 48 h and total RNA was extracted and purified using TRI Reagent and RNeasy Mini kit (Qiagen). RNA-seq was performed at the Molecular and Genomics Core Facility of the University of Mississippi Medical Center.

Statistical Analyses
--------------------

Data were compared with a two-tailed Student's *t*-test or a Mann-Whitney U test GraphPad Prism software (version 6.0), with *p* \< 0.05 considered statistically significant.

Data Availability
=================

RNA-seq results have been deposited in the NCBI BioProject database (Accession: [PRJNA385324](PRJNA385324)). All the other data supporting the findings of this study are available within the article and its Supplementary Information files, or are available from the authors upon request.
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